Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Oxford contributes to UK–China health reform discussions at Chevening forum

Dr Stuart Faulkner represented the Chevening Health Reform Fellowship at the inaugural Chevening Health Research Forum (CHERF) in China, an event jointly hosted by the UK government, the University of Oxford, and the British Chamber of Commerce in China. The forum brought together leading academics and policy specialists to strengthen UK–China collaboration on health reform and showcase research supported by the Fellowship Programme.

Attendees at the inaugural Chevening Health Research Forum (CHERF) in China.

Dr Stuart Faulkner, representing the Chevening Health Reform Fellowship run through Oxford Lifelong Learning, attended the inaugural Chevening Health Research Forum (CHERF) in China.

The forum – jointly hosted by the UK government, the University of Oxford, and the British Chamber of Commerce in China – aims to establish an annual academic platform for universities and leading healthcare institutions from both countries to exchange research and explore approaches to health reform.

Building on the UK–China Health Dialogue held in May 2025, CHERF brought together researchers, policy specialists, and former Chevening Fellows for a series of strategic discussions. Among the contributors was Professor Irene Tracey, Vice-Chancellor of the University of Oxford.

 Dr Faulkner delivered a presentation outlining the support Fellows can expect during their time in Oxford and chaired one of the panel sessions.

 

Read the full story on the Nuffield Department of Primary Care Health Science website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience